State Of Wisconsin Investment Board Aldeyra Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.11 - $8.16 $5,663 - $7,564	-927 Reduced 2.26%	40,077 $267,000
Q2 2023 Aug 14, 2023	BUY	$7.11 - $11.89 $291,538 - $487,537	41,004 New	41,004 $344,000
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $152,361 - $304,095	-62,700 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.44 - $14.85 $654,588 - $931,095	62,700 New	62,700 $710,000
Q3 2020 Nov 16, 2020	SELL	$4.0 - $7.53 $88,400 - $166,413	-22,100 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.97 - $5.05 $43,537 - $111,605	22,100 New	22,100 $92,000
Q3 2019 Nov 12, 2019	SELL	$4.41 - $6.12 $134,064 - $186,048	-30,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.0 - $9.0 $4,200 - $6,300	700 Added 2.36%	30,400 $182,000
Q1 2019 May 13, 2019	BUY	$7.14 - $9.85 $86,394 - $119,185	12,100 Added 68.75%	29,700 $268,000
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $119,680 - $252,560	17,600 New	17,600 $243,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $279M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.